Page 13 of 19 · 436 questions tagged vendor-vetting.
The specifics, since they change the answer: 96.8% · semaglutide · JEEP. I would like to define my thresholds before I have a result, for obvious reasons. I want a…
Conditions: chromatogram · GGPeps. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result, which…
The lot number on the vial matches the certificate, which at least rules out the easy problem. I want to know whether this is a real physical effect or an artefact of…
I am comparing a supplier certificate against an independent result on the same lot. I would like to know the limits of what can be inferred from this. What I am…
Conditions: QST · Wuhan Wansheng Biotechnology. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know that, so…
This is my second independent submission on material from the same supplier. I understand the observation; what I do not understand is the mechanism behind it. I have…
Stated plainly: purity figure · KP. I would like help reading this properly rather than being told what conclusion to reach. I have the full report including the…
Numbers first: 97.9% · dulaglutide · GL Biochem. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me…
Numbers first: 95.2% · orforglipron · SSA. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me which work…
Details up front: 97.6% · orforglipron · QYB. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum…
What I have: sampling plan · ERP. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
Numbers first: batch certificate · QSC. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
The particulars: 98.4% · ecnoglutide · JEEP. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping…
I have both a purity figure and a content figure, which is why the discrepancy is visible. An unexpected observation, and I would like a differential rather than…
I have the report as a PDF with the chromatogram on page two, so I can quote specifics. I am asking for verification rather than opinion, ideally with something I can…
What I have: cagrilintide · purity figure. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
Numbers first: SWB · Bachem Holding (Suzhou). I have used one of these for a while and I am considering switching, which requires a reason. What I care about is…
The case in front of me: Homopeptide · tirzepatide. I think I have a problem. I am not yet sure whether it is a real problem or a measurement artefact. I want to know…
The lane and the lead time matter as much as the material for what I am doing. I want a method I can write down and repeat, not a rule of thumb. I would rather…
Conditions: 97.1% · oral semaglutide · QSC. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would like…
What I am working with: QSC · mazdutide. I noticed this today and I have not touched anything since, in case the state is diagnostic. I have not discarded anything…
Concretely: Homopeptide · oral semaglutide. I think I have a problem. I am not yet sure whether it is a real problem or a measurement artefact. I want to know whether…
For reference: MKM · semaglutide. Somebody stated this to me confidently and I would like to check it before repeating it. I would accept a well-reasoned negative…
The particulars: oral semaglutide · chromatogram. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…